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Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever in rural areas of China and is caused 
by a new bunyavirus, SFTSV, named after the disease. The transmission vectors and animal hosts of SFTSV are unclear. Ticks 
are the most likely transmission vectors and domestic animals, including goats, dogs, and cattle, are potential amplifying hosts 
of SFTSV. The clinical symptoms of SFTS are nonspecific, but major symptoms include fever, gastrointestinal symptoms, 
myalgia, dizziness, joint pain, chills, and regional lymphadenopathy. The most common abnormalities in laboratory test results 
are thrombocytopenia (95%), leukocytopenia (86%), and elevated levels of serum alanine aminotransferase, aspartate ami-
notransferase, creatine kinase, and lactate dehydrogenase. The fatality rate for SFTS is 12% on average, and the annual inci-
dence of the disease is approximately five per 100000 of the rural population. 
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In June 2009, an outbreak of an unknown infectious disease 
occurred in rural areas of Hubei Province, China, affecting 
17 patients, five of whom died. A rickettsiologist, Dr. Yu 
Xue-Jie, was asked by the Chinese Center for Disease Con-
trol and Prevention (China CDC) to investigate the potential 
etiological pathogen of the disease, which was suspected to 
be human anaplasmosis (HA) [1]. After careful analysis of 
the patients’ clinical information, Dr. Yu concluded that the 
patients’ symptoms were inconsistent with HA because 
most had gastrointestinal symptoms, such as nausea, vomit-
ing, and diarrhea, which are rarely observed in HA patients 
[2]. Moreover, Dr. Yu’s laboratory detected no antibodies 
directed against the HA pathogen, Anaplasma phagocytoph-
ilum, or its DNA in any of the 17 patients. Therefore, Dr. 
Yu considered that the disease was not HA, but was more 
likely to be of viral origin, although previous studies had 
failed to identify a viral pathogen. A strategy was designed 
to isolate the etiological agent using multiple cell lines, in-
cluding DH82, Vero, Vero E6, THP-1, and IS6 cells, in an 
attempt to isolate A. phagocytophilum, Ehrlichia, Rickettsia, 
or a virus. After inoculation with a blood sample from a 
patient in June 2009, a cell cytopathic effect (CPE) was 
observed in DH82 cells and the virus was observed with 
electron microscopy. The genomic sequence indicated that 
the agent was a novel virus, most closely related to Phlebo-
virus in the family Bunyaviridae [3]. After the identification 
of the virus, the China CDC undertook a surveillance pro-
gram in 2010 and identified viral infections in six provinces 
of east China [2]. The virus was first designated “DBM vi-
rus”, because it was isolated from a patient living in the 
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DaBie Mountain area [4], but was renamed severe fever 
with thrombocytopenia syndrome virus (SFTSV) by the 
China CDC [3,5]. Similar viruses have recently been identi-
fied in both the United States and Japan [6]. 
1  SFTSV and its molecular biology 
Electron microscopy showed that SFTSV is spherical, with 
a diameter of 100 nm (Figure 1). The virions were observed 
inside vacuoles, presumably in the Golgi apparatus [3]. 
SFTSV is sensitive to acid, heat, and chemicals such as 
ether and sodium deoxycholate [7]. 
The genome of SFTSV consists of three RNA segments: 
the large (L), medium (M), and small (S) segments [3]. The 
L segment contains 6368 nucleotides, with one open read-
ing frame encoding 2084 amino acids. The M segment con-
tains 3378 nucleotides, with one open reading frame encod-
ing a 1073-amino-acid glycoprotein (Gn and Gc) precursor. 
The S segment contains 1744 nucleotides of ambisense 
RNA, encoding two proteins, the N and NSs proteins, in 
opposite orientations, separated by a 62-bp intergenic region. 
The 3 and 5 ends are complementary and can form a pan-
handle structure. The S segment is relatively conserved be-
tween SFTSV and other phleboviruses, with 41% amino 
acid sequence homology, whereas the L and M segments 
are less conserved, with only 21%–36% amino acid se-
quence homology between SFTSV and the other phlebo-
viruses [3]. SFTSV is most closely related to the Heartland 
virus, recently isolated from patients in the USA, with nearly 
70% RNA sequence homology. SFTSV is next closely relat-
ed to the Uukuniemi virus and Bhanja virus [3,8,9]. 
Phylogenetic, evolutionary, and structural analyses of all 
available SFTSV genomic sequences revealed recombina-
tion of SFTSV in the M and L segments [10]. A mosaic L 
segment sequence, which has descended from two major  
 
 
Figure 1  Hemorrhage in the mouth of a patient with SFTS.  
circulating lineages of SFTSV in China, represents the first 
evidence that homologous recombination plays a role in 
SFTSV evolution. Selection analyses indicated that negative 
selection is predominant in the SFTSV genes, yet the dif-
ferences in the selective forces among genes are consistent 
with those of the other Phlebovirus species. 
2  Transmission route, vectors, and animal 
hosts of SFTSV 
Except for Hantavirus, the bunyavirusesare usually main-
tained in arthropod vectors by transovarial transmission, 
whereas their vertebrate hosts may act as amplifying hosts 
[11]. SFTSV RNA has been detected in the ticks Haema-
physalis longicornis and Boophilus microplus collected 
from domestic animals, including cattle, goats, and dogs 
[3,12]. It has also been detected by PCR in Leptotrombidium 
scutell mites collected from Apodemusagrarius mice, in 
Laelaps echidnina mites collected from A. agrarius and 
goats in Jiangsu Province [13], and in the gadfly in Henan 
Province [14]. SFTSV was not detected in mosquitoes [3] 
and has not yet been investigated in the sandfly. SFTSV has 
not been detected in tick eggs and has been detected in only 
tick collected from vegetation [12]. The arthropods positive 
for SFTSV suggest that they could be vectors of SFTSV or 
that they could acquire SFTSV from infected animals. 
Therefore, these arthropods should be further investigated 
as vectors of SFTSV. 
The seroprevalence of SFTSV has been investigated in 
domestic animals, including goats, dogs, cattle, pigs, and 
chickens. In Shandong Province, 83%–95% of goats were 
positive for SFTSV antibodies [15–17]; in Jiangsu Province, 
57% of goats, 32% of cattle, 6% of dogs, 5% of pigs, and 
1% of chickens were seropositive for SFTSV [17]; and in 
Hubei Province, 55.0% (6/11) of dogs, 36.7% (2/3) of goats, 
and 80.0% (4/5) of cattle were seropositive for SFTSV [18]. 
However, only a small proportion of the animals studied 
(1.7%–5.3%) were found to carry low levels of viral RNA 
in their sera [19]. This suggests that the domesticated ani-
mals act as amplifying hosts of SFTSV and play a major 
role in feeding the ticks that spread SFTSV. Rats were se-
ropositive for SFTSV in Jiangsu Province, at a rate of 6.9% 
in wild rodents and 7.87% in house rodents [20]. The sero-
prevalence of SFTSV in other wild animal species has not 
been investigated. 
3  Nosocomial transmission of SFTSV 
The nosocomial transmission of SFTSV has been demon-
strated in several studies [21–24]. The earliest confirmed 
nosocomial transmission occurred in 2006 in Anhui Prov-
ince [21], when SFTSV was most likely transmitted from 
person to person through contact with the patient’s blood 
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[21]. The incubation period of nosocomial transmission is 
between six and 13 days after contact with or exposure to 
the blood of an index patient [21]. 
4  Geographical distribution and seasonal out-
breaks 
SFTS patients have been identified in 16 provinces of east 
China [25] (Figure 2). SFTS has occurred most frequently 
in central China, especially in Henan, Hubei, and Shandong 
Province, which have reported 48.2%, 21.9%, and 15.7% of 
the total SFTS cases, respectively [26]. These cases of 
SFTS were sporadic and occurred predominantly in hilly 
areas. SFTS occurred from April to November in different 
areas of China and 96.0% (148/154) of laboratory-con-     
firmed cases occurred nationally between May and July [3]. 
5  Susceptible population 
The ages of SFTS patients ranged from 1 to 90 years, with a 
median age of 58 years [26]. People aged over 50 years 
constituted 75% of cases but only 26% of the population 
under surveillance (P<0.001). Fifty-six percent of cases 
were female, although they constitute only 49% of the total 
population (P=0.029), and 97% of cases were farmers living 
in wooded and hilly areas and working in the fields. Precise 
information about the occupations of the total population 
under surveillances was not available [27]. SFTSV mainly 
infected older persons, which suggests that SFTSV infects 
people with low immunity. 
Serosurveillance indicated that 1.0%–3.8% of the popu-
lation in the hilly areas of China were positive for SFTSV 
antibodies [15–17], suggesting that although a large popula-
tion was infected with SFTSV, a very small proportion of  
 
 
Figure 2  The provinces in China where SFTSV and SFTS patients were 
identified until 2012. 
infected individuals developed the disease. The incidence of 
SFTS ranged from 0.33/104 in Hubei Province to 5/105 in 
Shandong Province [18] (unpublished). 
6  Clinical symptoms and diagnosis of SFTS 
The clinical symptoms of SFTS are nonspecific, but the 
major symptoms include fever, gastrointestinal symptoms, 
myalgia, and regional lymphadenopathy. Dizziness (31.3%), 
joint pain (25%), and chills (18.8%) are also common in 
SFTSV-infected patients, and hemorrhage in mouth is also 
frequently observed. The most common abnormalities on 
laboratory tests are thrombocytopenia (95%) and leuko-
cytopenia (86%). Proteinuria (in 84% of patients) and he-
maturia (in 59%) are also observed [3]. Multiple organ fail-
ure develops rapidly in most patients, as evident in their 
elevated levels of serum alanine aminotransferase, aspartate 
aminotransferase, creatine kinase, and lactate dehydrogen-
ase. The case fatality rate of SFTS was about 11%–12% in 
2009 and 2010, with one study reporting 21 deaths in 171 
confirmed cases from the whole country and another study 
reporting 21 deaths in 188 cases in Hubei Province in 2010 
[3,18]. The national mortality rate was 6.3% (129/2047) in 
2011 and 2012 [26]. The reason for the improvement in the 
mortality rate from 2010 to 2012 is unclear, but might have 
resulted from the different sample sizes and/or the early 
diagnosis and proper treatment of patients after the identifi-
cation of SFTSV. Patients with SFTS have severe clinical 
symptoms, and progress rapidly to multiple organ dysfunc-
tion syndrome (MODS), with a high fatality rate of 
12%–30% [3]. Multiorgan failure is associated with death 
and the SFTS patients with MODS who died were older and 
had lower platelet counts than those who survived [28]. 
Mortality was significantly higher in misdiagnosed SFTS 
patients than in patients with confirmed SFTS (16% vs. 
6.1%, respectively) [28]. The treatment for SFTS is non-
specific and the results of treatment are difficult to evaluate 
because there have been no cohort studies. 
The diagnosis of SFTSV infection is based on the pa-
tient’s clinical manifestations, such as fever, thrombocyto-
penia (and/or leukopenia), and elevated levels of liver en-
zymes, and on their living and working environments, spe-
cifically in rural areas with forests and shrubs. Confirmation 
of SFTSV infection requires one of the following conditions: 
isolation of SFTSV from the patient’s serum, detection of 
SFTSV RNA in the patient’s serum by PCR, or detection of 
SFTS antibodies in the patient’s serum. Several methods 
have been developed to amplify the viral RNA, including 
reverse transcription-PCR (RT-PCR) and RT-loop-mediated 
isothermal amplification (RT-LAMP) [29–32]. Amplifica-
tion of the S segment is the most sensitive RT-PCR assay 
[29]. A simple near-instrument-free molecular method that 
incorporates RT-cross-priming amplification (RT-CPA) 
coupled to a vertical-flow visualization strip has also been 
700 Zhang X S, et al.   Sci China Life Sci   August (2013) Vol.56 No.8 
developed for the rapid detection of SFTSV [32]. To detect 
viral antibodies, an enzyme-linked immunosorbent assay 
(ELISA) has been developed using a recombinant N protein 
of SFTSV [17]. Virus isolated from blood is mainly used in 
research laboratories and CDCs. The SFTSV virus can be 
isolated using DH82 cells, which are round monocytes be-
fore infection but attach to the culture flask after infection 
with the virus [3]. SFTSV exerts a CPE on DH82 cells but 
not on Vero cells or Vero E6 cells in primary isolation, 
which may be why isolation of SFTSV was failed for such a 
long time in China, because Vero E6 cells were used in the 
past. A serological test for the diagnosis of SFTSV infection 
could be developed using immunofluorescence or ELISA [3]. 
7  Control and prevention of SFTSV 
SFTS is a severe disease, with a high case fatality rate, that 
occurs in areas of China with high population densities. The 
primary hosts for H. longicornis in China are domestic ani-
mals, including goats, sheep, cattle, and dogs. Controlling 
ticks on these animals with chemicals is essential to reduc-
ing the tick population and to reducing SFTSV infections in 
humans. No vaccine for SFTSV has yet been developed. 
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